NCT00358488View on ClinicalTrials.gov

Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

GSK159797 (10, 15, and 20mcg)

GSK159797 (10, 15, and 20mcg)

DRUG

salbutamol

salbutamol

DRUG

salmeterol 50mcg

salmeterol 50mcg

DRUG

placebo

placebo

Trial Locations (6)

14057

GSK Investigational Site, Berlin

65187

GSK Investigational Site, Wiesbaden

115446

GSK Investigational Site, Moscow

3584 CJ

GSK Investigational Site, Utrecht

SE-221 85

GSK Investigational Site, Lund

M23 9LT

GSK Investigational Site, Manchester

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY